Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Macula Stories

2011-04-25 13:50:00

WEST PALM BEACH, Fla., April 25, 2011 /PRNewswire/ -- The ophthalmic therapeutics company Xcovery Vision announced today that Sheridan G. Snyder, OBE, Chairman and CEO, and Dr. Ken Mandell, President and COO, will be speaking at The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale Florida, May 1-5, 2011. Mr. Snyder's talk Perspective of a Serial Entrepreneur recounts his repeated success as founder of multiple biotech companies that include...

2011-04-20 08:30:00

MARLBOROUGH, Mass., April 20, 2011 /PRNewswire/ -- Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that it has filed a clinical trial application (CTA) with the European Medicines and Healthcare products Regulatory Agency (MHRA) seeking clearance to initiate its Phase 1/2 clinical trial using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular...

2011-04-07 09:00:00

NEW YORK, April 7, 2011 /PRNewswire-USNewswire/ -- Every 18 months, the Macula Vision Research Foundation hosts a conference that brings together industry-leading retinal scientists, clinicians and medical equipment developers. This year, 25 participants were invited to share their work and collaborate with one another in an interactive setting at the Four Seasons Hotel in New York. Dr. Samuel G. Jacobson, M.D. Ph.D., Scheie Eye Institute, University of Pennsylvania, discussed his...

2011-03-24 08:30:00

BIRMINGHAM, Ala., March 24, 2011 /PRNewswire/ -- Macular Health, a Birmingham-based company offering products for those suffering with macular degeneration, recently announced its new Dry Eye Formula supplement. The new vitamin is the fourth product in the Macular Health brand family and helps to reduce dry eye symptoms, including burning, stinging, redness and intermittent visual disturbances that currently affect more than 12 million people nationwide. Macular Health LLC partnered with...

2011-03-16 07:10:00

ST. LOUIS, March 16, 2011 /PRNewswire/ -- ZeaVision, LLC announced that its Zeaxanthin-based nutraceutical, EyePromise Restore, has been improved with a 25% increase in Omega 3's and the addition of Vitamin D3. EyePromise Restore increases low macular pigment density, a risk factor for Age-Related Macular Degeneration (AMD), and people have an opportunity to win a bottle of EyePromise Restore at http://www.amdchallenge.com, a website designed to create awareness around AMD. EyePromise...

2011-02-08 12:10:18

An international scientific team has announced the discovery of a trigger for the commonest form of vision loss and blindness in older people western society. Their findings, achieved with help from Australian eye donors, could lead to ways to treat a disease that has until now been regarded as untreatable. Researchers from Australia and the United States reported in the current issue of the journal Nature their finding that a critical enzyme is lacking in patients suffering untreatable...

2010-12-24 13:00:11

Every Australian child should learn to wear sunglasses outdoors to avoid the risk of vision loss later in life. Researchers at The Vision Centre say there is strong scientific evidence that bright light harms our vision cells and cumulative damage causes loss of sight in old age. However there are several steps which everyone can take to reduce the risk of long-term damage, they say. The earlier vision protection begins, the more effective it will be, says Professor Jan Provis, Associate...

2010-12-20 00:10:00

TARRYTOWN, N.Y., Dec. 20, 2010 /PRNewswire-FirstCall/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that it will hold a teleconference and webcast at 8:30 a.m. Eastern Time on Monday, December 20, to discuss results of the Phase 3 COPERNICUS study with VEGF Trap-Eye in central retinal vein occlusion (CRVO) and the week 52 follow-up results of the Phase 2 DA VINCI study in patients with diabetic macular edema (DME). A press release will be issued prior to the call....

2010-12-08 08:43:00

BIRMINGHAM, Ala., Dec. 8, 2010 /PRNewswire/ -- According to a recent study, the Macular Health vitamin supplement dissolves up to five and a half times faster than other leading eye vitamin supplements. The study indicated that Macular Health, which slows the progression of vision loss due to age-related macular degeneration (AMD), dissolves in 12 minutes, with competing brands taking up to 65 minutes to dissolve. This news is important to macular degeneration sufferers because the US...

2010-12-07 19:01:00

Scientists at The Vision Centre have found new evidence that the common blinding disease macular degeneration (MD) may result from poorly regulated immune responses similar to those linked to Alzheimer's disease or cerebral haemorrhages. The leading cause of vision loss and blindness in Australia, macular degeneration often occurs as a result of the immune system going into overdrive and killing more vision cells than it should, according to new evidence found by PhD student Matt Rutar from...